MEGIN

MEGIN TRIUX™ neo

Advanced Magnetoencephalography (MEG)

The TRIUX™ neo is the world’s most advanced functional neuroimaging system, delivering unparalleled precision in Magnetoencephalography (MEG). Designed for both clinical diagnostics and cutting-edge research, it provides real-time, non-invasive visualization of patient-specific neural activity with millimeter spatial accuracy and millisecond temporal resolution.

TRIUX™ neo sets a new benchmark in functional brain mapping, empowering clinicians and researchers to make confident, data-driven decisions in complex neurological conditions.

Key Features & Innovations

• Ultra-Resilient ARMOR™ Sensors: Next-generation sensor technology delivering industry-leading signal-to-noise ratios with instant recovery from magnetic artifacts caused by dental implants, stimulators, or external interference.
• Signal-Level Movement Compensation: Patented motion compensation technology that eliminates artifacts caused by head movement—ideal for pediatric patients, infants, and individuals with involuntary motion.
• Zero Boil-Off Helium Recycling: Integrated Internal Helium Recycler (IHR) eliminates helium loss, significantly reducing operating costs and environmental impact.
• Flexible Patient Positioning: Supports seated, reclined, or supine positioning with adjustable height for maximum patient comfort during extended scans.

MEG Maps™ – End-to-End Clinical Platform

MEG Maps™ is a unified clinical platform powered by TRIUX™ neo and MEGreview™, designed to seamlessly bridge advanced research with routine patient care.

• Presurgical Evaluation: Accurate localization of epileptogenic zones and mapping of eloquent cortex, including language, motor, and sensory regions.
• Multimodal Integration: Seamless fusion of MEG data with MRI, fMRI, PET, and SPECT to generate a comprehensive functional brain roadmap.
• Secure Data Management: DICOM integration with PACS archiving ensures secure, standardized, and accessible clinical data across hospital networks.

Clinical & Research Impact

“The TRIUX™ neo enables clinicians to localize brain function with millimeter precision, confirm diagnoses when other modalities are inconclusive, and significantly reduce surgical risk.” 

• Epilepsy & Neurology: Identification of seizure foci and functional connectivity patterns invisible to conventional MRI.
• Neurosurgery: High-precision functional mapping to guide tumor and lesion resections while preserving critical brain functions.
• Translational Research: Discovery of biomarkers for neurodegenerative and neuropsychiatric disorders such as Alzheimer’s, Parkinson’s, and schizophrenia.

Redefining Precision in Brain Mapping

With unmatched accuracy, resilience, and clinical integration, the MEGIN TRIUX™ neo represents the gold standard in MEG technology—advancing neuroscience research and transforming patient care.